Sixth Trial of Potential Chinese Covid-19 Vaccine Begins with GSK, Dynavax Mix

China now accounts for almost half of the clinical trials testing COVID-19 vaccines, including candidates from CanSino Biological, and Sinopharm and the Wuhan Institute of Biological Products.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.